HOME CAREERS CONTACT
 
Press Releases
All Releases
View Summary OrthoLogic Announces Positive Safety Data for Initial AZX100 Phase 1 Human Clinical Trial in Dermal/Hypertrophic Scarring
May 8, 2008
PDF 9.4 KB
View Summary OrthoLogic Announces First Quarter 2008 Financial Results and Conference Call
May 7, 2008
PDF 13.1 KB
View Summary OrthoLogic Announces Year End 2007 Operating Results and Stock Repurchase Program
Mar 5, 2008
PDF 18.1 KB
View Summary OrthoLogic Announces Initiation of Dosing for AZX100 Phase 1 Human Clinical Trial in Dermal/Hypertrophic Scarring
Feb 29, 2008
PDF 8.9 KB
View Summary OrthoLogic to Host Conference Call Discussing Year-End 2007 Financial Results
Feb 27, 2008
PDF 8.2 KB
View Summary Orthologic Announces FDA Acceptance of AZX100 IND Application in Dermal/Hypertrophic Scarring; Phase 1 Human Clinical Trial to Begin 1Q2008
Jan 28, 2008
PDF 9.2 KB
View Summary OrthoLogic Announces Third Quarter 2007 Financial Results
Nov 5, 2007
PDF 13.8 KB
View Summary OrthoLogic to Host Conference Call Discussing Third Quarter 2007 Results
Oct 31, 2007
PDF 7.7 KB
View Summary Orthologic to Present At the Bio Investor Forum 2007 October 10, 2007 -- San Francisco, CA
Oct 5, 2007
PDF 7.1 KB
View Summary OrthoLogic to Present At the Wall Street Analyst Forum September 20, 2007 -- New York, NY
Sep 17, 2007
PDF 7.8 KB
View Summary OrthoLogic To Present At The First Albany Capital Regenerative Technologies Conference
Sep 6, 2007
PDF 6.3 KB
View Summary OrthoLogic Announces Second Quarter 2007 Financial Results
Aug 8, 2007
PDF 20.2 KB
View Summary OrthoLogic Establishes Scientific Advisory Board
Aug 2, 2007
PDF 11.2 KB
View Summary OrthoLogic Announces First Quarter 2007 Financial Results
May 7, 2007
PDF 15.1 KB
View Summary OrthoLogic Announces Year End 2006 Financial Results
Mar 14, 2007
PDF 20.2 KB
View Summary OrthoLogic to Host Conference Call Discussing Year-End 2006 Results
Mar 7, 2007
PDF 10.6 KB
View Summary OrthoLogic Announces Results of Post Hoc Subgroup Analysis of Data From Phase 3 Clinical Trial of Chrysalin (TP508) in Fracture Repair
Feb 16, 2007
PDF 14.3 KB
View Summary Phase 1/2 Clinical Trial Results to be Published Reporting Beneficial Effects of OrthoLogic's Chrysalin (TP508) in Treatment of Diabetic Foot Ulcers
Jan 25, 2007
PDF 14.7 KB
View Summary Studies of OrthoLogic's Chrysalin(R) (TP508) Show Specific Receptor Binding Activity and Effects in Human Endothelial Cells
Dec 11, 2006
PDF 14.6 KB
View Summary OrthoLogic Announces Third Quarter 2006 Financial Results
Nov 2, 2006
PDF 17.3 KB
Showing 1-20 of 25 Page: 1 2  Next 20
       
Copyright © 2007 OrthoLogic. All Rights Reserved. | Legal Disclaimer